This book is a critical reflection on the current global epidemic of mental disease, and with that, the global proliferation of mental health professionals and the expanding discourse on mental illness. Over the past 35 years, scientific ideas on mental pathology from the designated experts on the mind have seeped outwards from the psychiatric institution into many spheres of public and private life. It is part of my role as a sociologist to explain how this epidemic has come about and the extent to which it is a valid reflection of real medical progress in the area. I am not alone in undertaking such a project; other social scientists—as well as psychiatrists and psychologists themselves—have investigated the recent expansion in the varieties of mental disorder and their usage among western populations, and have voiced similar concerns to the ones that I will articulate in this book. However, as the title suggests, this work goes further than most other scholars and mental health experts appear able to. This is because I frame the business of mental health within its wider structural context, within a system of power relations of which economic exploitation is the determinant one. Ignoring the development and current dynamics of capitalist society has been a significant omission of most other scholarship in the area; this is my contribution to getting critical social theory back to the heart of research and scholarship in the sociology of mental health.
“We are,” according to the psychotherapist James Davies (2013: 1), “a population on the brink.” The figures for mental disease suggest that not only are we currently in the grip of an illness epidemic but we are nearing a tipping point towards catastrophe: out of a global population of seven billion inhabitants, 450 million people are estimated to be currently affected by a mental or behavioural disorder (World Health Organization 2003: 4), with 100 million of them taking psychotropic drugs (Chalasani 2016: 1184). The projected rates in developed countries such as the United States and the United Kingdom are even higher with one in four people suffering from a mental disorder each year (Davies 2013: 1). The World Health Organization (WHO) (2003: 5) estimates that the expenditure on mental health problems in western society amounts to between 3 and 4 per cent of gross national product; the cost in the United States alone is over $100 billion per year (Wilkinson and Pickett 2010: 65). By 2020, according to the WHO, depression—a disease which will affect one-fifth of all Americans at some point in their life (Horwitz and Wakefield 2007: 4)—will be “the second leading cause of worldwide disability, behind only heart disease” (Horwitz and Wakefield 2007: 5).
Consequently, the WHO (2003: 3) states of this mental illness epidemic that “[t]he magnitude, suffering and burden in terms of disability and costs for individuals, families and societies are staggering.” From being a relatively rare affliction just 60 years ago, mental illness is now everybody’s concern. Whitaker (2010a: 6–7) has noted of this change that the rates of debilitating mental illness among US adults has increased sixfold between 1955 and 2007. However, the “plague of disabling mental illness” as he calls it has fallen particularly hard on young people in the country, with an incredible 35-fold increase between 1997 and 2007. This makes mental disease the “leading cause of disability in children” in the United States (Whitaker 2010a: 8). The varieties of known mental illnesses have also increased over time, with the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM) identifying 106 mental disorders in 1952, yet 374 today (Davies 2013: 2).
In the current milieu it is no surprise that the power and influence of the mental health professionals are—like the above statistics—“growing at a remarkable rate” (Davies 2013: 2). However, as every critical scholar on the topic is aware, very serious problems remain with the current science and practice within the mental health system. These concerns inevitably lead us to questioning the reality of the claims to a mental illness “epidemic” made by health organisations such as the APA and the WHO, and to ask who really benefits from the global expansion of the psychiatric discourse. An essential issue here is the continuing contested nature of “mental illness,” for there remains no proof that any “mental disorder” is a real, observable disease. Consequently, the “experts” still cannot distinguish the mentally ill from the mentally healthy. In fact, a recent attempt by the APA—the most powerful psychiatric body in the world—to define mental illness was bluntly described by one of their most senior figures as “bullshit” (see discussion below). Accordingly, it also follows that no “treatment” has been shown to work on any specific “mental illness” and that there is no known causation for any disorder. Of course, these issues are highly disputed by many mental health professionals, so the evidence and debates are outlined in detail in the chapters that follow.
I appreciate that questioning the validity of mental illness comes as little comfort to those people who are currently experiencing stress, trauma, or behaviour which causes what Thomas Szasz (1974) has previously referred to as “problems in living.” Let me clarify briefly here that this book is not denying such experience; rather it is questioning the discourse of “mental illness” which is produced by groups of professionals who claim an expert knowledge over this experience. Therefore, the current discussion is a critique of professional power not of personal experience and behaviour which may have been labelled (or self-labelled) as a “mental illness.” Though my previous work has investigated the multifaceted meanings of illness and recovery for those so labelled (see, e.g., Cohen 2015), this is not the focus of the current book. Instead, the issue at hand is how to explain the incredible expansion of what we might call the “mental health industry”—that is, the entirety of the professionals, businesses, and discourse surrounding the area of mental health and illness—without a concurrent progression in the scientific evidence on mental pathology. The next section briefly explores some of the main explanations given for the dominance of the current mental health system and the gaps in this work.
Critical Scholarship on Mental Illness
Most commonly, critical scholars focus on one major reason for the current expansion in the numbers and categories of mental illness in western society—namely, the influence of pharmaceutical corporations (colloquially referred to as “big pharma”) on the construction of new categories of disorder and the promotion of drug solutions for those disorders (see, e.g., Davies 2013; Healy 2004; Moncrieff 2009; Moynihan and Cassels 2005; Whitaker 2010a; Whitaker and Cosgrove 2015). The institution of psychiatry is the ultimate authority responsible for defining and treating mental pathologies, yet commentators argue that the profession has been steadily compromised by forming close relationships with big pharma, who are now effectively setting the mental health agenda. For example, critics point to the 69 per cent of psychiatrists responsible for the development of the latest edition of the DSM (DSM-5, see American Psychiatric Association 2013) who have financial ties to the pharmaceutical industry (Cosgrove and Wheeler 2013: 95). Research has also demonstrated the close involvement of big pharma in the development of current mental illness categories including social anxiety disorder (SAD) (Lane 2007) and premenstrual dysphoric disorder (PMDD) (Cosgrove and Wheeler 2013). The more behaviour and experience that can be successfully medicalised—that is, reconceptualised as in need of medical intervention—through this medico-industrial partnership, the more drugs can be potentially sold to the public. Thus it is argued that the expansion of the mental illness discourse is the result of a market takeover of health care; corporations rather than medical practitioners are now designating what mental pathology is and, as a result, dictating treatment. The obvious solution to this situation involves the de-coupling of mental health services from the influence of big business. Tighter government regulation and oversight of pharmaceutical corporations is required, as is transparency within the relevant professional organisations.
While this critique of big pharma’s intervention in the production and promotion of the contemporary psychiatric discourse is relevant, it is perhaps the least surprising aspect of the operation of the mental health system within capitalist society. Scholars of medical history such as Andrew Scull (1989, 1993, 2015), for example, have profiled a continuing “trade in lunacy” which can be traced back to the beginnings of industrial society and witnessed throughout the development of modern mental health work. That the market is part of the workings of psychiatry and related professions should be self-evident to any scholar aware of the history of the mental health system in western society. Such critics would also acknowledge that while psychiatry legitimates the products of big pharma, pushing psychopharmaceuticals in turn helps legitimate the psychiatric profession. The prescribing of drugs is a key symbol of modern doctoring which serves to align psychiatric practice with other branches of medicine through a shared biomedical understanding of health and illness.
The medico-industrial relationship described above has raised an associated criticism from critical scholars as to the efficacy of the biomedical approach in understanding mental health problems more generally. Biomedicine conceptualises disease as a physical pathology of the body. Thus, biomedical psychiatry theorises mental disorder as having a physical aetiology (causation) that can be observed, measured, and treated. Modern psychiatry focuses on the brain as the organ that causes such “disease,” and most often regards mental illness as the result of faulty neurotransmitters or “chemical imbalances” in the brain. The biomedical approach to understanding mental illness have been a part of psychiatry since its emergence over 200 years ago, yet has become increasingly dominant within the mental health system since the 1980s (Chap. 2). According to critics, however, despite its current “hegemonic” moment (Cosgrove and Wheeler 2013: 100), bio-psychiatry lacks the legitimacy of scientific evidence. The scholars blame corrupt individuals and powerful interests both inside and outside of psychiatry for reiterating biomedical myths regarding the “normal” and “abnormal” workings of the brain so as to be able to promote physical interventions such as drugs and electroconvulsive therapy (ECT) as potential “cures” for mental illness. Such writers note the continuing lack of proof of biological causation for any mental disorder, the potential for corruption at the hands of big pharma, the perversion of the psychiatric profession by particular self-interested, powerful parties and individuals, and the reductionist nature of the biomedical model which is seen to have damaged the founding aims of the profession to improve the care and treatment of people who suffer from mental disorders and to always perform their duties in the best interests of the patient (see, e.g., Bentall 2009; Breggin 1991; Davies 2013; Greenberg 2013; Whitaker and Cosgrove 2015).
Critics call for an understanding of mental disorder which goes beyond biological reductionism to consider psychological, social, and environmental factors which correlate with mental illness. Often conceptualised as the “psychosocial model” (or simply, the “social model”) of mental illness, scholars and experts highlight a range of evidence from socio-economic data which demonstrates that such factors as family income, educational level, ethnic group, geographical location, and social class are all closely related to the chances of developing a mental health problem. While the social model suggests that we all have the potential to suffer mental disorders if exposed to traumatic situations, some groups are particularly vulnerable to mental illness due to experiencing comparatively more stressful life conditions and, at the same time, having less access to cultural and economic resources which can alleviate the threat of mental problems. As the WHO’s (2013) recent Mental Health Action Plan 2013–2020 has emphasised,
Depending on the local context, certain individuals and groups in society may be placed at a significantly higher risk of experiencing mental health problems. These vulnerable groups may (but do not necessarily) include members of households living in poverty, people with chronic health conditions, infants and children exposed to maltreatment and neglect, adolescents first exposed to substance use, minority groups, indigenous populations, older people, people experiencing discrimination and human rights violations, lesbian, gay, bisexual, and transgender persons, prisoners, and people exposed to conflict, natural disasters or other humanitarian emergencies.
Interventions are then aimed at the personal and the social; therapy and counselling allows individuals to work through their disorder with trained professionals, while community health services target certain deprived communities for mental health promotions and the additional resourcing of mental illness prevention teams.
Explanations for the increase in rates of mental illness given by socially orientated models of mental health, therefore, draw attention to the widening social inequalities experienced in neolibe...